Literature DB >> 32106476

OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.

Maho Murata1, Takamichi Ito1, Yuka Tanaka1, Kazuhiko Yamamura1, Kazuhisa Furue1, Masutaka Furue1,2,3.   

Abstract

Progression of actinic keratosis (AK) to cutaneous squamous cell carcinoma (cSCC) is rare. Most cases of AK remain as intraepidermal lesions, owing to the suppression of the epithelial-to-mesenchymal transition (EMT). Ovo-like transcriptional repressor 1 (OVOL1) and ovo-like zinc finger 2 (OVOL2) are important modulators of EMT in some tumors, but their roles in skin tumors remain elusive. This study elucidated the roles of OVOL1/2 in AK and cSCC using 30 AK/30 cSCC clinical samples, and an A431 human SCC cell line using immunohistochemistry and molecular biological approaches. Immunohistochemically, OVOL1/2 were upregulated in AK and downregulated in cSCC. Meanwhile, EMT-related factors, vimentin and zinc finger E-box binding homeobox 1 (ZEB1) were downregulated in AK and upregulated in cSCC. Moreover, ZEB1 expression was higher in tumors in which OVOL2 expression was low. Thus, we observed an inverse association between OVOL2 and ZEB1 expression in AK and cSCC. Although knockdown of OVOL1 or OVOL2 increased the mRNA and protein levels of ZEB1, only OVOL2 knockdown increased the invasive ability of A431. In conclusion, OVOL2 inhibits ZEB1 expression and may inhibit the promotion of AK into cSCC. OVOL2/ZEB1 axis may be a potential target for preventing the development of cSCC.

Entities:  

Keywords:  E-cadherin; EMT; OVOL1; OVOL2; Snail; Twist1; ZEB1; actinic keratosis; cutaneous squamous cell carcinoma; vimentin

Year:  2020        PMID: 32106476     DOI: 10.3390/jcm9030618

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

Review 1.  A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review).

Authors:  Benjamin Genenger; Jay R Perry; Bruce Ashford; Marie Ranson
Journal:  Discov Oncol       Date:  2022-06-06

2.  NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.

Authors:  Maho Murata; Takamichi Ito; Yuka Tanaka; Yumiko Kaku-Ito; Masutaka Furue
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

3.  MiR-139-5p-ZEB1 is a Molecular Regulator of Growth, Invasion, and Epithelial-to-Mesenchymal Transition of Cervical Cancer.

Authors:  Jinrui Sun; Shanshan Wang; Ping Liu; Yulan Liu
Journal:  Cancer Manag Res       Date:  2020-12-10       Impact factor: 3.989

4.  TROP2 Expression in Sebaceous and Sweat Gland Carcinoma.

Authors:  Takamichi Ito; Hiroki Hashimoto; Yuka Tanaka; Keiko Tanegashima; Maho Murata; Toshio Ichiki; Takeshi Iwasaki; Yoshinao Oda; Yumiko Kaku-Ito
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

5.  OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor.

Authors:  Chuannan Fan; Qian Wang; Gerard van der Zon; Jiang Ren; Cedrick Agaser; Roderick C Slieker; Prasanna Vasudevan Iyengar; Hailiang Mei; Peter Ten Dijke
Journal:  Signal Transduct Target Ther       Date:  2022-04-29

6.  miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker.

Authors:  Weronika Tomaszewska; Joanna Kozłowska-Masłoń; Dawid Baranowski; Anna Perkowska; Sandra Szałkowska; Urszula Kazimierczak; Patricia Severino; Katarzyna Lamperska; Tomasz Kolenda
Journal:  Biomedicines       Date:  2021-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.